These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 34541178)
21. Standardization of the teratoma assay for analysis of pluripotency of human ES cells and biosafety of their differentiated progeny. Gropp M; Shilo V; Vainer G; Gov M; Gil Y; Khaner H; Matzrafi L; Idelson M; Kopolovic J; Zak NB; Reubinoff BE PLoS One; 2012; 7(9):e45532. PubMed ID: 23049812 [TBL] [Abstract][Full Text] [Related]
22. Teratoma formation by human embryonic stem cells is site dependent and enhanced by the presence of Matrigel. Prokhorova TA; Harkness LM; Frandsen U; Ditzel N; Schrøder HD; Burns JS; Kassem M Stem Cells Dev; 2009; 18(1):47-54. PubMed ID: 18393673 [TBL] [Abstract][Full Text] [Related]
23. Noninvasive detection of human-induced pluripotent stem cell (hiPSC)-derived teratoma with an integrin-targeting agent (99m)Tc-3PRGD2. Li Y; Liu Z; Dong C; He P; Liu X; Zhu Z; Jia B; Li F; Wang F Mol Imaging Biol; 2013 Feb; 15(1):58-67. PubMed ID: 22707047 [TBL] [Abstract][Full Text] [Related]
24. Development of experimental tumors formed by mouse and human embryonic stem and teratocarcinoma cells after subcutaneous and intraperitoneal transplantations into immunodeficient and immunocompetent mice. Gordeeva OF; Nikonova TM Cell Transplant; 2013; 22(10):1901-14. PubMed ID: 23051679 [TBL] [Abstract][Full Text] [Related]
25. Teratoma: from spontaneous tumors to the pluripotency/malignancy assay. Bulic-Jakus F; Katusic Bojanac A; Juric-Lekic G; Vlahovic M; Sincic N Wiley Interdiscip Rev Dev Biol; 2016; 5(2):186-209. PubMed ID: 26698368 [TBL] [Abstract][Full Text] [Related]
26. Generation of disease-specific induced pluripotent stem cells from patients with different karyotypes of Down syndrome. Mou X; Wu Y; Cao H; Meng Q; Wang Q; Sun C; Hu S; Ma Y; Zhang H Stem Cell Res Ther; 2012 Apr; 3(2):14. PubMed ID: 22512921 [TBL] [Abstract][Full Text] [Related]
28. Continuous expression of reprogramming factors induces and maintains mouse pluripotency without specific growth factors and signaling inhibitors. Mao Y; Wang L; Zhong B; Yang N; Li Z; Cui T; Feng G; Li W; Zhang Y; Zhou Q Cell Prolif; 2021 Aug; 54(8):e13090. PubMed ID: 34197016 [TBL] [Abstract][Full Text] [Related]
29. In vivo reprogrammed pluripotent stem cells from teratomas share analogous properties with their in vitro counterparts. Choi HW; Kim JS; Hong YJ; Song H; Seo HG; Do JT Sci Rep; 2015 Aug; 5():13559. PubMed ID: 26315499 [TBL] [Abstract][Full Text] [Related]
30. Functional assays for human embryonic stem cell pluripotency. O'Connor MD; Kardel MD; Eaves CJ Methods Mol Biol; 2011; 690():67-80. PubMed ID: 21042985 [TBL] [Abstract][Full Text] [Related]
31. Rapid generation of secondary fibroblasts through teratoma formation. Cho SM; Park JS; Min B; Kwon S; Kang YK Biotechniques; 2015 Jul; 59(1):34-41. PubMed ID: 26156782 [TBL] [Abstract][Full Text] [Related]
32. Establishment of the removal method of undifferentiated induced pluripotent stem cells coexisting with chondrocytes using R-17F antibody. Miyazaki T; Hanamatsu H; Onodera T; Furukawa JI; Xu L; Homan K; Baba R; Kawasaki T; Iwasaki N Regen Med; 2022 Nov; 17(11):793-803. PubMed ID: 36154668 [No Abstract] [Full Text] [Related]
33. Generation and periodontal differentiation of human gingival fibroblasts-derived integration-free induced pluripotent stem cells. Yin X; Li Y; Li J; Li P; Liu Y; Wen J; Luan Q Biochem Biophys Res Commun; 2016 May; 473(3):726-32. PubMed ID: 26456649 [TBL] [Abstract][Full Text] [Related]
34. Generation of mice derived from induced pluripotent stem cells. Boland MJ; Hazen JL; Nazor KL; Rodriguez AR; Martin G; Kupriyanov S; Baldwin KK J Vis Exp; 2012 Nov; (69):e4003. PubMed ID: 23222420 [TBL] [Abstract][Full Text] [Related]
36. ERas is expressed in primate embryonic stem cells but not related to tumorigenesis. Tanaka Y; Ikeda T; Kishi Y; Masuda S; Shibata H; Takeuchi K; Komura M; Iwanaka T; Muramatsu S; Kondo Y; Takahashi K; Yamanaka S; Hanazono Y Cell Transplant; 2009; 18(4):381-9. PubMed ID: 19622226 [TBL] [Abstract][Full Text] [Related]
37. In vivo differentiation potential of buffalo (Bubalus bubalis) embryonic stem cell. Verma OP; Kumar R; Nath A; Sharma M; Dubey PK; Kumar GS; Sharma GT In Vitro Cell Dev Biol Anim; 2012 Jun; 48(6):349-58. PubMed ID: 22678753 [TBL] [Abstract][Full Text] [Related]
38. Induced pluripotent stem cell lines derived from human gingival fibroblasts and periodontal ligament fibroblasts. Wada N; Wang B; Lin NH; Laslett AL; Gronthos S; Bartold PM J Periodontal Res; 2011 Aug; 46(4):438-47. PubMed ID: 21443752 [TBL] [Abstract][Full Text] [Related]
39. Generation of porcine-induced pluripotent stem cells by using OCT4 and KLF4 porcine factors. Liu K; Ji G; Mao J; Liu M; Wang L; Chen C; Liu L Cell Reprogram; 2012 Dec; 14(6):505-13. PubMed ID: 23035653 [TBL] [Abstract][Full Text] [Related]
40. Attenuation of teratoma formation by p27 overexpression in induced pluripotent stem cells. Matsu-ura T; Sasaki H; Okada M; Mikoshiba K; Ashraf M Stem Cell Res Ther; 2016 Feb; 7():30. PubMed ID: 26880084 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]